These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19105608)

  • 1. Differential potencies of naturally occurring regioisomers of nitrolinoleic acid in PPARgamma activation.
    Alexander RL; Wright MW; Gorczynski MJ; Smitherman PK; Akiyama TE; Wood HB; Berger JP; King SB; Morrow CS
    Biochemistry; 2009 Jan; 48(2):492-8. PubMed ID: 19105608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of nitrated lipid signaling by multidrug resistance protein 1 (MRP1): glutathione conjugation and MRP1-mediated efflux inhibit nitrolinoleic acid-induced, PPARgamma-dependent transcription activation.
    Alexander RL; Bates DJ; Wright MW; King SB; Morrow CS
    Biochemistry; 2006 Jun; 45(25):7889-96. PubMed ID: 16784241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.
    Schopfer FJ; Lin Y; Baker PR; Cui T; Garcia-Barrio M; Zhang J; Chen K; Chen YE; Freeman BA
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2340-5. PubMed ID: 15701701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereocontrolled synthesis of the PPAR-gamma agonist 10-nitrolinoleic acid.
    Dunny E; Evans P
    J Org Chem; 2010 Aug; 75(15):5334-6. PubMed ID: 20593759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potencies.
    Bates DJ; Smitherman PK; Townsend AJ; King SB; Morrow CS
    Biochemistry; 2011 Sep; 50(36):7765-73. PubMed ID: 21827153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncatalytic interactions between glutathione S-transferases and nitroalkene fatty acids modulate nitroalkene-mediated activation of peroxisomal proliferator-activated receptor gamma.
    Bates DJ; Lively MO; Gorczynski MJ; King SB; Townsend AJ; Morrow CS
    Biochemistry; 2009 May; 48(19):4159-69. PubMed ID: 19358561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
    Schopfer FJ; Cole MP; Groeger AL; Chen CS; Khoo NK; Woodcock SR; Golin-Bisello F; Motanya UN; Li Y; Zhang J; Garcia-Barrio MT; Rudolph TK; Rudolph V; Bonacci G; Baker PR; Xu HE; Batthyany CI; Chen YE; Hallis TM; Freeman BA
    J Biol Chem; 2010 Apr; 285(16):12321-33. PubMed ID: 20097754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner.
    Vangaveti VN; Shashidhar VM; Rush C; Malabu UH; Rasalam RR; Collier F; Baune BT; Kennedy RL
    Lipids; 2014 Dec; 49(12):1181-92. PubMed ID: 25330944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
    Singh S; Bennett RG
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.
    Tsukahara T; Tsukahara R; Yasuda S; Makarova N; Valentine WJ; Allison P; Yuan H; Baker DL; Li Z; Bittman R; Parrill A; Tigyi G
    J Biol Chem; 2006 Feb; 281(6):3398-407. PubMed ID: 16321982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators.
    Fujimura T; Sakuma H; Konishi S; Oe T; Hosogai N; Kimura C; Aramori I; Mutoh S
    J Pharmacol Sci; 2005 Dec; 99(4):342-52. PubMed ID: 16314690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation.
    Gorczynski MJ; Smitherman PK; Akiyama TE; Wood HB; Berger JP; King SB; Morrow CS
    J Med Chem; 2009 Aug; 52(15):4631-9. PubMed ID: 19719236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.
    Seargent JM; Yates EA; Gill JH
    Br J Pharmacol; 2004 Dec; 143(8):933-7. PubMed ID: 15533890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones are partial agonists for the glucocorticoid receptor.
    Matthews L; Berry A; Tersigni M; D'Acquisto F; Ianaro A; Ray D
    Endocrinology; 2009 Jan; 150(1):75-86. PubMed ID: 18801908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of PPARγ agonist activities of stereo-, regio-, and enantio-isomers of hydroxyoctadecadienoic acids.
    Umeno A; Sakashita M; Sugino S; Murotomi K; Okuzawa T; Morita N; Tomii K; Tsuchiya Y; Yamasaki K; Horie M; Takahara K; Yoshida Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.
    Morgado M; Carson DD
    J Cell Biochem; 2017 Jan; 118(1):163-171. PubMed ID: 27292441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Moss PE; Lyles BE; Stewart LV
    Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.